| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-06 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.16 | 0.0008 |